To determine whether upregulated expression of MFRN1 affects mitochondrial iron content in glioma cells, we treated control and MFRN1-overexpressing cells with Mito-FerroGreen, a fluorescent mitochondrial-targeted iron probe that labels ferrous iron [33]. Here, SLC25A37 is linked to central nervous system cancer.